DAFTAR PUSTAKA Penggunaan Obat-Obatan Penginduksi Penyakit Hati terhadap Pasien Gangguan Fungsi Hati di RSUD Dr. Moewardi Tahun 2013.
38
DAFTAR PUSTAKA
Aithal, P.G., Day, C.P., 1999, The Natural History of Histologically Proved Drug
Induced Liver Disease. GUT, 44:731–735.
Andreasen, P.B., Handel, J., Greisen, G., Hvidberg, E.F., 1976, Pharmacokinetics
of diazepam in disorder liver function, European Journal of Clinical
Pharmacology, 10:115-120
Arinzon, Z., Arinzon, P., Berner, Y., 2004, Hydrochlorothiazide induced hepatocholestatic liver injury, Age and Ageing, 1-2
Badan POM RI, 2008, Informatorium Obat Nasional Indonesia, Jakarta.
Caldwell, S.H., Hespenheide, E.E., Borstel, R.W., 2001, Myositis, microvesicular
hepatitis, and progression to cirrhosis from troglitazone added to
simvastatin. Digest Dis Sci.; 46: 376.
Cinthya, S.E., Ivan, S.P., dan Rizky, A., 2012, Penggunaan Obat Penginduksi
Kerusakan Hati pada Pasien Rawat Inap Penyakit Hati di Salah Satu
Rumah Sakit di Kota Tasikmalaya, Jurnal Farmasi Klinik Indonesia, 1
(2).
Conant, R., Schauss, A.G., 2004, Therapeutic Applications of Citicoline for
Stroke and Cognitive Dysfunction in the Elderly: A Review of the
Literature, Alternative Medicine Review, 9:17-31.
Costinela, G., Mihai, N., 2012, Research On Ceftazidime - Induced Neurotoxicity
In -Patients With Renal Diseases, Fascicula XVII, 2:55-58
Department of Health and Human Services Food and Drug Administration,
2009, Guidance for Industry Drug-Induced Liver Injury: Premarketing
Clinical Evaluation, Department of Health and Human Services Food and
Drug Administration Center for Drug Evaluation and Research
(CDER) Center for Biologics Evaluation and Research (CBER), US.
Depkes RI, 2003, Farmakologi jilid II, Departemen Kesehatan RI, Jakarta.
Depkes RI, 2007, Pharmaceutical Care untuk Penyakit Hati, Departemen
Kesehatan RI, Jakarta.
Deng, X., James P. Luyendyk, Patricia E. Ganey, and Robert A. Roth. 2009.
Inflammatory Stress and Idiosyncratic Hepatotoxicity: Hints from
Animal Models. Pharmacological Reviews. Vol. 61, No. 3.
39
Dipiro, J.T., Talbert, R.L., Yee, G.C., Matzke, G.R., Wells, B.G., and Posey, L.
M., 2005. Pharmacotherapy Handbook Sixth. McGraw-Hill
Company. USA.
Dourakis SP, 2008, Drug Therapy in Liver Diseases. Annals Of Gastroenterology,
21(4) : 215- 217.
Ehrenpreis, S., Ehrenpreis E.D., 2001, Clinician’s handbook of Prescription
Drugs: McGraw-Hill Companies.
Fancher, T.L., Kamboj, A., Onate, J., 2007, Patients’ elevated LFT results can
indicate hepatocyte injury, cholestasis, or both, Current Psychiatry, 6(5):
61-68
Fontana, B.J., Shakil, O., Greenson, J.K., Boyd, I., & Lee, W.M., 2005, Acute
Liver Failure Due to Amoxocillin and Amoxicillin/Clavulanate, Digestive
Dideases and Sciences, 50(10);1785-1790.
Friedman, S.L., 2008, Clinins in Liver Disease, Division of liver diseases,
NewYork.
Ganong, W.F., 2008. Buku Ajar Fisiologi Kedokteran. Jakarta : EGC. pp : 519.
Gerber, T., Schomerus, H., 2000, Hepatic Encephalopathy in Liver Cirrhosis:
pathogenesis, diagnosis, and management. Drugs; 60(6): 1353-7
Guy, J. & Peters, M. G., 2013, Liver Disease in Women: The Influence of Gender
on Epidemiology, Natural History, and Patient Outcomes, Gastoenterology
and Hepatology, 9, 10
Grattagliano, I., Leonilde Bonfrate, Catia V Diogo, Helen H Wang, David QH
Wang, and Piero Portincasa. 2009. Biochemical mechanisms in druginduced liver injury: Certainties and doubts. World J Gastroenterol.
15(39): 4865–4876.
Grieco, A., et al, 2005, Fatty liver and Drugs, Europen Review for Medical and
Pharmacological Sciences, 9: 261-263.
Grimbert, S., Pessayre, D., Degott C., Benhamou, J.P., 2006, Acute hepatitis
induced by HMG-CoA reductase inhibitor, lovastatin. Digest Dis Sci.; 39:
2032–2033.
Gutkowski, K., Chwist, A., Hartleb, M, 2011, Liver Injury Induced by High-Dose
metylprednisolone Therapy : A Case Report and Brief Review of the
Literature. Hepat Mon. 11(8): 656-61
40
Hadari, Nawawi., 2005, Metode Penelitian Bidang Sosial, Yogyakarta: Gadjah
Mada University Press.
Hussein, Z., Granneman, G.R., Mukherjee, D, 2008, Age-related differences in the
pharmacokinetics and pharmacodynamics of lansoprazole, Br. J. Clin.
Pharmacol, 36: 391–8.
Isabel, M., et al, 2008, Assessment of drug-induced liver injury in clinical
practice Assessment of drug-induced liver injury in clinical practice,
Agencia Espan˜-ola del Medicamento and from the Fondo de
Investigacio´ n Sanitaria.
John R. Senior. 2005. Recognizing Drug-Induced Liver Injury (DILI) in Exposed
Populations. Pharmacoepidemiology and Statistical Science Food and
Drug Administration (FDA). United State of America.
Kanathur, N., Mathai, M.G., Byrd, R.P., Fields, C.L., Roy, T.M., 2001,
Simvastatin- Diltiazem drug interaction resulting in rhabdomyolysis and
hepatitis. Tennessee Med.; 94: 339–341.
Kaplan, L.A., Pesce JA, 1989, Clinical Chemistry: Theory Analysis and
Corelation. Edisi ke-3, New York: Mosby.
Kaplowitz, N., 2007, Drug-Induced Liver Disease. Second Edition. Informa
Healthcare USA, Inc. New York. 1-717.
Koolman, J,.Rohm., K.H., 1995, Atlas Berwarna dan Teks Biokimia. Wanandi SI,
penerjemah; Jakarta: Hipokrates. Terjemahan dari: Color Atlas of
Biochemistry.
Kshirsagar, A., Vetal, Y., Ashok, P., Bhosle, P., and Ingawale, D., Drug Induced
Hepatotoxicity: A Comprehensive Review. The Internet Journal of
Pharmacology. 2008 Volume 7 Number 1.
Larson, A.M., et al. 2005. Acetaminophen-Induced Acute Liver Failure: Results
of a United
States Multicenter, Prospective Study. Hepatology.
42:1364-1372.
Lawrence SF.Liver, 2003, Current Medical Diagnosis & Treatment. San
Fransisco: McGraw Hill,628:73
Lee D., 2012, Drug Induced Liver Disease. URL : www.medicineNet.com. July,
26.
Lu F.C., 1995. Toksikologi Dasar: Asas, Organ, Sasaran, dan Penilaian Risiko.
Edisi ke-2. Jakarta: UI press.
41
Lucena, M.I., Cortes, M.G., Cueto, R., Duran, J.L.L., dan Andrade, R.J., 2008,
Assessment of Drug Induced Injuy in Clinical Practice, Fundamental &
Clinical Pharmacology, 10.
Magueur, R., Hagege, H., Attali, P., Singlas, E., Etienne, J.P., & Taburet, A.m.,
1991, Pharmacokinetics of Metoclopramide in Patients with Liver
Cirrhosis, Br J clin Pharmac, 31;185-187.
Martin, D.W., Mayes, P.A., Rodwell, V.W., 1984, Biokimia, Dharma A,
Kurniawan AS; Jakarta: EGC Penerbit Buku Kedokteran. Terjemahan
dari: Review of Biochemistry.
Mengel, M.B., 1996, Family Medicine Ambulatory Care & Prevention 4 th
edition, Mc Graw Hill Boston-London-Singapore-Toronto. p. 268-272.
MIMS, 2008, MIMS Indonesia Petunjuk Konsultasi, Edisi 8, Jakarta.
Moore, K.P., Aithal, G.P., 2006, Guidelines on the Management of Ascites in
Cirrhosis, Gut BMJ Journals, 55; 1-12.
Murray, K.F., 2008, Drug Related Hepatotoxicity and Acute Liver Failure,
Journal of Pediatric Gastroenterology and Nutrition, 47: 395-405.
Nakad, A., Bataille, L., Hamoir, V., Sempoux, C., Horsman, Y., 1999,
Atorvastatin-induced acute hepatitis with absence of cross-toxicity with
simvastatin. Lancet.; 353: 1763–1764.
Navarro, VJ., dan Senior, J.R., 2006, Drug Related hepatotoxicity, N England
Journal Med, 354, 731.9
Ndraha, S., 2013, Kolestasis Intrahepatik, Ckd-207, 40: 567-561.
Nederlands Bijwerkingen Centrum Lareb, 2013, Ceftriaxone and Hepatitis,
Nederlands Bijwerkinged Centrun Nederland Pharmacovigilance Center.
Nurjanah S. Sirosis hati, 2007, Ilmu penyakit dalam. Jakarta: Pusat Penerbitan
Fakultas Kedokteran Universitas Indonesia, 443:46
Oktaviani, I., 2012, Aspek Farmakokinetik Klinik Obat-Obatan yang Digunakan
Pasien Sirosis Hati di Bangsal Interne RSUP Dr. M. Djamil Padang
Periode Oktober 2011- Januari 2012, Laporan Penelitian, Padang.
Pauls, L.L., dan Senior, J.R., 2012, Drug Induce Liver Injury, Clinical
Investigator Training Course.
42
Pelli, N., Setti, M., Cepp,,a P., Toncini C., Indiveri. F., 2003, Autoimmune
hepatitis revealed by atorvastatin. Eur J Gastroen Hepat.; 15: 921-924.
Prescott, L.F., Wright, N., Roscoe, P. & Brown, S.S., 1971, Plasma Paracetamol
Half-Life and Hepatic Necrosis in Patients with Paracetamol Overdose,
Lancet, i, 519-522.
Reuben, A., Koch, D.G., Lee, W.M., 2010, Drug-Induced Acute Liver Failure:
results of a U.S. Multicenter Prospective Study, Hepatology, 52:20652076.
Rosenberg, L., et al, 1980, Thiazides and Acute Cholecystitis, N Engl J
Med,303:548.
Setiabudy, R., 1979, Hepatitis Karena Obat, Cermin Dunia Kedokteran,15: 8-12.
Simmons, F., Feldman, B., and Gerety, B., 1972, Granulomatous Hepatitis In A
Patient Receiving Allopurinol, Gastroenterology. 62(1).
Sonderup, M.W., 2006, Drug Induced Liver Injury is a Significant Cause of Liver
Disease, Including Chronic Liver, Drug Induced Liver Injuries, 29(6).
Sutadi, S.M., 2003, Sirosis Hepatitis, Bagian Ilmu Penyakit Dalam, FK Sumatera
Utara.
Tajiri K and Shimizu Y. 2008. Practical Guidelines for Diagnosis and Early
Management of Drug-Induced Liver Injury. World J Gastroenterol.
14(44): 6774–6785
Tandon, R.K., 2012, Prescribing in patients with liver disease, Medicine Update.
22, 294-297.
Thomson, A.B.R., Shaffer, E.A., 2012, First Principles of Gastroenterologt the
Basis of Disease and an Approach to Management, Gastroenterology,
5:(525).
Tibesar, E., Karwowski, C., Hertel, P., Scheimann, A., and Karnsakul, W., 2014,
Two Cases of Progressive Familial Intrahepatic Cholestasis Type 2
Presenting with Severe Coagulopathy without Jaundice, Case Reports in
Pediatrics,:1-5
Timbrell, J., A., 1983, Drug Hepatotoxocity, Br J clin Pharmacology, 15, 3-14.
Toole, G., Susan, 1999, Understanding Biology for Advanced Level Stanley
Tornes: Cheintenham.
43
Topal, F., Ersan. O., Sabiye.A., Metin. K., Osman, Y., Emin. A., 2006,
Methylprednisolone-induced toxic hepatitis. Ann Pharmacother 40(10):
1868-1871.
Urata, Y., Okita, K., Korenaga, K., Uchida, K., Yamasaki, T., Sakaida, I., 2007,
The effect of supplementation with branched chain amino acids in patients
with liver cirrhosis, Hepatol Res,37(7):510:6
Wai, CT., 2006, Presentation of drug-induced liver injury in Singapore, Singapore
Medical Journal, 47(2) : 116.
Whitcomb, D.C & Block, G.D. 1994. Association of Acetaminophen
Hepatotoxicity with Fasting and Ethanol Use. JAMA, 272: 1845–50.
Vatansever, S., 2012, Irbesartan-induced autoimmune hepatitis, akademik
gastroenteroloji dergisi, 11 (1): 35-38.
Verma,S., Kaplowitz, N., 2009, Diagnosis, Management and Prevention of DrugInduced Liver Injury, Department of Medicine, Brighton and Sussex
Medical School, Brighton, UK.
Vial T, Goubier C, Bergeret A, Cabrera F, Evreux JC, and Descotes J., 1991, Side
Effects of Ranitidine. Drug Saf 6:94–117.
Zinsser, P., Wys, B.M., Rich, P., 2004, Hepatotoxicity induced by celecoxib and
amlodipine, Swiss Med Wkly, 134:201
DAFTAR PUSTAKA
Aithal, P.G., Day, C.P., 1999, The Natural History of Histologically Proved Drug
Induced Liver Disease. GUT, 44:731–735.
Andreasen, P.B., Handel, J., Greisen, G., Hvidberg, E.F., 1976, Pharmacokinetics
of diazepam in disorder liver function, European Journal of Clinical
Pharmacology, 10:115-120
Arinzon, Z., Arinzon, P., Berner, Y., 2004, Hydrochlorothiazide induced hepatocholestatic liver injury, Age and Ageing, 1-2
Badan POM RI, 2008, Informatorium Obat Nasional Indonesia, Jakarta.
Caldwell, S.H., Hespenheide, E.E., Borstel, R.W., 2001, Myositis, microvesicular
hepatitis, and progression to cirrhosis from troglitazone added to
simvastatin. Digest Dis Sci.; 46: 376.
Cinthya, S.E., Ivan, S.P., dan Rizky, A., 2012, Penggunaan Obat Penginduksi
Kerusakan Hati pada Pasien Rawat Inap Penyakit Hati di Salah Satu
Rumah Sakit di Kota Tasikmalaya, Jurnal Farmasi Klinik Indonesia, 1
(2).
Conant, R., Schauss, A.G., 2004, Therapeutic Applications of Citicoline for
Stroke and Cognitive Dysfunction in the Elderly: A Review of the
Literature, Alternative Medicine Review, 9:17-31.
Costinela, G., Mihai, N., 2012, Research On Ceftazidime - Induced Neurotoxicity
In -Patients With Renal Diseases, Fascicula XVII, 2:55-58
Department of Health and Human Services Food and Drug Administration,
2009, Guidance for Industry Drug-Induced Liver Injury: Premarketing
Clinical Evaluation, Department of Health and Human Services Food and
Drug Administration Center for Drug Evaluation and Research
(CDER) Center for Biologics Evaluation and Research (CBER), US.
Depkes RI, 2003, Farmakologi jilid II, Departemen Kesehatan RI, Jakarta.
Depkes RI, 2007, Pharmaceutical Care untuk Penyakit Hati, Departemen
Kesehatan RI, Jakarta.
Deng, X., James P. Luyendyk, Patricia E. Ganey, and Robert A. Roth. 2009.
Inflammatory Stress and Idiosyncratic Hepatotoxicity: Hints from
Animal Models. Pharmacological Reviews. Vol. 61, No. 3.
39
Dipiro, J.T., Talbert, R.L., Yee, G.C., Matzke, G.R., Wells, B.G., and Posey, L.
M., 2005. Pharmacotherapy Handbook Sixth. McGraw-Hill
Company. USA.
Dourakis SP, 2008, Drug Therapy in Liver Diseases. Annals Of Gastroenterology,
21(4) : 215- 217.
Ehrenpreis, S., Ehrenpreis E.D., 2001, Clinician’s handbook of Prescription
Drugs: McGraw-Hill Companies.
Fancher, T.L., Kamboj, A., Onate, J., 2007, Patients’ elevated LFT results can
indicate hepatocyte injury, cholestasis, or both, Current Psychiatry, 6(5):
61-68
Fontana, B.J., Shakil, O., Greenson, J.K., Boyd, I., & Lee, W.M., 2005, Acute
Liver Failure Due to Amoxocillin and Amoxicillin/Clavulanate, Digestive
Dideases and Sciences, 50(10);1785-1790.
Friedman, S.L., 2008, Clinins in Liver Disease, Division of liver diseases,
NewYork.
Ganong, W.F., 2008. Buku Ajar Fisiologi Kedokteran. Jakarta : EGC. pp : 519.
Gerber, T., Schomerus, H., 2000, Hepatic Encephalopathy in Liver Cirrhosis:
pathogenesis, diagnosis, and management. Drugs; 60(6): 1353-7
Guy, J. & Peters, M. G., 2013, Liver Disease in Women: The Influence of Gender
on Epidemiology, Natural History, and Patient Outcomes, Gastoenterology
and Hepatology, 9, 10
Grattagliano, I., Leonilde Bonfrate, Catia V Diogo, Helen H Wang, David QH
Wang, and Piero Portincasa. 2009. Biochemical mechanisms in druginduced liver injury: Certainties and doubts. World J Gastroenterol.
15(39): 4865–4876.
Grieco, A., et al, 2005, Fatty liver and Drugs, Europen Review for Medical and
Pharmacological Sciences, 9: 261-263.
Grimbert, S., Pessayre, D., Degott C., Benhamou, J.P., 2006, Acute hepatitis
induced by HMG-CoA reductase inhibitor, lovastatin. Digest Dis Sci.; 39:
2032–2033.
Gutkowski, K., Chwist, A., Hartleb, M, 2011, Liver Injury Induced by High-Dose
metylprednisolone Therapy : A Case Report and Brief Review of the
Literature. Hepat Mon. 11(8): 656-61
40
Hadari, Nawawi., 2005, Metode Penelitian Bidang Sosial, Yogyakarta: Gadjah
Mada University Press.
Hussein, Z., Granneman, G.R., Mukherjee, D, 2008, Age-related differences in the
pharmacokinetics and pharmacodynamics of lansoprazole, Br. J. Clin.
Pharmacol, 36: 391–8.
Isabel, M., et al, 2008, Assessment of drug-induced liver injury in clinical
practice Assessment of drug-induced liver injury in clinical practice,
Agencia Espan˜-ola del Medicamento and from the Fondo de
Investigacio´ n Sanitaria.
John R. Senior. 2005. Recognizing Drug-Induced Liver Injury (DILI) in Exposed
Populations. Pharmacoepidemiology and Statistical Science Food and
Drug Administration (FDA). United State of America.
Kanathur, N., Mathai, M.G., Byrd, R.P., Fields, C.L., Roy, T.M., 2001,
Simvastatin- Diltiazem drug interaction resulting in rhabdomyolysis and
hepatitis. Tennessee Med.; 94: 339–341.
Kaplan, L.A., Pesce JA, 1989, Clinical Chemistry: Theory Analysis and
Corelation. Edisi ke-3, New York: Mosby.
Kaplowitz, N., 2007, Drug-Induced Liver Disease. Second Edition. Informa
Healthcare USA, Inc. New York. 1-717.
Koolman, J,.Rohm., K.H., 1995, Atlas Berwarna dan Teks Biokimia. Wanandi SI,
penerjemah; Jakarta: Hipokrates. Terjemahan dari: Color Atlas of
Biochemistry.
Kshirsagar, A., Vetal, Y., Ashok, P., Bhosle, P., and Ingawale, D., Drug Induced
Hepatotoxicity: A Comprehensive Review. The Internet Journal of
Pharmacology. 2008 Volume 7 Number 1.
Larson, A.M., et al. 2005. Acetaminophen-Induced Acute Liver Failure: Results
of a United
States Multicenter, Prospective Study. Hepatology.
42:1364-1372.
Lawrence SF.Liver, 2003, Current Medical Diagnosis & Treatment. San
Fransisco: McGraw Hill,628:73
Lee D., 2012, Drug Induced Liver Disease. URL : www.medicineNet.com. July,
26.
Lu F.C., 1995. Toksikologi Dasar: Asas, Organ, Sasaran, dan Penilaian Risiko.
Edisi ke-2. Jakarta: UI press.
41
Lucena, M.I., Cortes, M.G., Cueto, R., Duran, J.L.L., dan Andrade, R.J., 2008,
Assessment of Drug Induced Injuy in Clinical Practice, Fundamental &
Clinical Pharmacology, 10.
Magueur, R., Hagege, H., Attali, P., Singlas, E., Etienne, J.P., & Taburet, A.m.,
1991, Pharmacokinetics of Metoclopramide in Patients with Liver
Cirrhosis, Br J clin Pharmac, 31;185-187.
Martin, D.W., Mayes, P.A., Rodwell, V.W., 1984, Biokimia, Dharma A,
Kurniawan AS; Jakarta: EGC Penerbit Buku Kedokteran. Terjemahan
dari: Review of Biochemistry.
Mengel, M.B., 1996, Family Medicine Ambulatory Care & Prevention 4 th
edition, Mc Graw Hill Boston-London-Singapore-Toronto. p. 268-272.
MIMS, 2008, MIMS Indonesia Petunjuk Konsultasi, Edisi 8, Jakarta.
Moore, K.P., Aithal, G.P., 2006, Guidelines on the Management of Ascites in
Cirrhosis, Gut BMJ Journals, 55; 1-12.
Murray, K.F., 2008, Drug Related Hepatotoxicity and Acute Liver Failure,
Journal of Pediatric Gastroenterology and Nutrition, 47: 395-405.
Nakad, A., Bataille, L., Hamoir, V., Sempoux, C., Horsman, Y., 1999,
Atorvastatin-induced acute hepatitis with absence of cross-toxicity with
simvastatin. Lancet.; 353: 1763–1764.
Navarro, VJ., dan Senior, J.R., 2006, Drug Related hepatotoxicity, N England
Journal Med, 354, 731.9
Ndraha, S., 2013, Kolestasis Intrahepatik, Ckd-207, 40: 567-561.
Nederlands Bijwerkingen Centrum Lareb, 2013, Ceftriaxone and Hepatitis,
Nederlands Bijwerkinged Centrun Nederland Pharmacovigilance Center.
Nurjanah S. Sirosis hati, 2007, Ilmu penyakit dalam. Jakarta: Pusat Penerbitan
Fakultas Kedokteran Universitas Indonesia, 443:46
Oktaviani, I., 2012, Aspek Farmakokinetik Klinik Obat-Obatan yang Digunakan
Pasien Sirosis Hati di Bangsal Interne RSUP Dr. M. Djamil Padang
Periode Oktober 2011- Januari 2012, Laporan Penelitian, Padang.
Pauls, L.L., dan Senior, J.R., 2012, Drug Induce Liver Injury, Clinical
Investigator Training Course.
42
Pelli, N., Setti, M., Cepp,,a P., Toncini C., Indiveri. F., 2003, Autoimmune
hepatitis revealed by atorvastatin. Eur J Gastroen Hepat.; 15: 921-924.
Prescott, L.F., Wright, N., Roscoe, P. & Brown, S.S., 1971, Plasma Paracetamol
Half-Life and Hepatic Necrosis in Patients with Paracetamol Overdose,
Lancet, i, 519-522.
Reuben, A., Koch, D.G., Lee, W.M., 2010, Drug-Induced Acute Liver Failure:
results of a U.S. Multicenter Prospective Study, Hepatology, 52:20652076.
Rosenberg, L., et al, 1980, Thiazides and Acute Cholecystitis, N Engl J
Med,303:548.
Setiabudy, R., 1979, Hepatitis Karena Obat, Cermin Dunia Kedokteran,15: 8-12.
Simmons, F., Feldman, B., and Gerety, B., 1972, Granulomatous Hepatitis In A
Patient Receiving Allopurinol, Gastroenterology. 62(1).
Sonderup, M.W., 2006, Drug Induced Liver Injury is a Significant Cause of Liver
Disease, Including Chronic Liver, Drug Induced Liver Injuries, 29(6).
Sutadi, S.M., 2003, Sirosis Hepatitis, Bagian Ilmu Penyakit Dalam, FK Sumatera
Utara.
Tajiri K and Shimizu Y. 2008. Practical Guidelines for Diagnosis and Early
Management of Drug-Induced Liver Injury. World J Gastroenterol.
14(44): 6774–6785
Tandon, R.K., 2012, Prescribing in patients with liver disease, Medicine Update.
22, 294-297.
Thomson, A.B.R., Shaffer, E.A., 2012, First Principles of Gastroenterologt the
Basis of Disease and an Approach to Management, Gastroenterology,
5:(525).
Tibesar, E., Karwowski, C., Hertel, P., Scheimann, A., and Karnsakul, W., 2014,
Two Cases of Progressive Familial Intrahepatic Cholestasis Type 2
Presenting with Severe Coagulopathy without Jaundice, Case Reports in
Pediatrics,:1-5
Timbrell, J., A., 1983, Drug Hepatotoxocity, Br J clin Pharmacology, 15, 3-14.
Toole, G., Susan, 1999, Understanding Biology for Advanced Level Stanley
Tornes: Cheintenham.
43
Topal, F., Ersan. O., Sabiye.A., Metin. K., Osman, Y., Emin. A., 2006,
Methylprednisolone-induced toxic hepatitis. Ann Pharmacother 40(10):
1868-1871.
Urata, Y., Okita, K., Korenaga, K., Uchida, K., Yamasaki, T., Sakaida, I., 2007,
The effect of supplementation with branched chain amino acids in patients
with liver cirrhosis, Hepatol Res,37(7):510:6
Wai, CT., 2006, Presentation of drug-induced liver injury in Singapore, Singapore
Medical Journal, 47(2) : 116.
Whitcomb, D.C & Block, G.D. 1994. Association of Acetaminophen
Hepatotoxicity with Fasting and Ethanol Use. JAMA, 272: 1845–50.
Vatansever, S., 2012, Irbesartan-induced autoimmune hepatitis, akademik
gastroenteroloji dergisi, 11 (1): 35-38.
Verma,S., Kaplowitz, N., 2009, Diagnosis, Management and Prevention of DrugInduced Liver Injury, Department of Medicine, Brighton and Sussex
Medical School, Brighton, UK.
Vial T, Goubier C, Bergeret A, Cabrera F, Evreux JC, and Descotes J., 1991, Side
Effects of Ranitidine. Drug Saf 6:94–117.
Zinsser, P., Wys, B.M., Rich, P., 2004, Hepatotoxicity induced by celecoxib and
amlodipine, Swiss Med Wkly, 134:201